OPi's Acquisition

OPi was acquired by EUSA Pharma on March 01, 2007.

OPi, which is headquartered in Lyon, France, develops and markets worldwide a range of specialty pharma drugs aimed at treating patients suffering from rare and severe diseases. Its primary focus is o…

Articles about OPi's Acquisition: